{
  "id": 20900291,
  "title": "This week in charts: Biotech investors’ China bets are already paying off",
  "url": "https://urgent.news/2026/11/20/this-week-in-charts-biotech-investors-china-bets-are-already-paying",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-20T12:00:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/biotech-china-deals-venture-returns-summit-stock/874912/"
  },
  "original_language": "en",
  "account": null,
  "summary": "This year, companies built around medicines from China have sped toward acquisitions or IPOs. Meanwhile, Summit is no longer the Wall Street darling it was in 2024.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}